Skip to main content

Intensive Care Unit

1
Pipeline Programs
4
Companies
3
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Eppendorf
EppendorfGermany - Hamburg
1 program
1
Fish OilPhase 21 trial
Active Trials
NCT06279793Recruiting550Est. Sep 2030
Pfizer
PfizerNEW YORK, NY
1 program
DexmedetomidineN/A1 trial
Active Trials
NCT01169571Completed373Est. Jun 2011
UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
Living conditionsN/A1 trial
Active Trials
NCT06524765Completed78Est. Oct 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
EppendorfFish Oil
UNION therapeuticsLiving conditions
PfizerDexmedetomidine

Clinical Trials (3)

Total enrollment: 1,001 patients across 3 trials

NCT06279793EppendorfFish Oil

Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients

Start: Feb 2024Est. completion: Sep 2030550 patients
Phase 2Recruiting
NCT06524765UNION therapeuticsLiving conditions

Intestinal Microbiota and Their Antibiotic Resistance Genes of ICU Health Care Workers

Start: Aug 2024Est. completion: Oct 202478 patients
N/ACompleted
NCT01169571PfizerDexmedetomidine

Study to Evaluate Hemodynamic Effect of Different Loading Doses of Precedex in Post-surgical Intensive Care Unit (ICU) Patients

Start: Sep 2010Est. completion: Jun 2011373 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 1,001 patients
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.